Clinical Trial

Retrospective and Prospective Evaluation of Scapulohumeral Comfort, Aesthetic Result and Quality of Life

Study acronym: QUARLAMI
Completed
View on ClinicalTrials.gov →
Summary
The dorsalis major flap is an interesting therapeutic option in breast reconstruction because of reliability and reproducibility. In recent years, the minimal flap technique has been developed, which consists of removing only a portion of the of the large dorsal muscle to reduce the painful and functional sequelae of this surgery. The objective of this prospective study is to evaluate the functional and aesthetic results in patients who have undergone who have undergone this procedure (prospective cohort) or who will undergo this procedure or prosthetic reconstruction (prospective cohort). The investigators also wish to evaluate the quality of life of patients after reconstruction with a minimal harvest dorsalis flap or a prosthesis or prosthesis in the prospective cohort.
Protocol Amendment History 2 changes
critical Trial completed 2026-08-13
minor Completion moved earlier: 2027-02-21 -> 2026-05-19 2026-08-13
Trial Details
NCT Number NCT05316389
Lead Sponsor Institut Cancerologie de l'Ouest
Conditions Breast Cancer
Enrollment 190 participants
Start Date 2022-02-21
Primary Completion 2026-05-19 (estimated)
Study Completion 2026-05-19 (estimated)
Updated on ClinicalTrials.gov 2026-08-12